Review





Similar Products

96
Selleck Chemicals ckd progression
Ckd Progression, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckd+progression/Tofacitinib/10__1096_slash_fj__202402318r-33-10-16
Average 96 stars, based on 1 article reviews
ckd progression - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology ckd – progression
Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
Ckd – Progression, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckd+progression/ckd+++progression/pmc11103316-75-7-5
Average 90 stars, based on 1 article reviews
ckd – progression - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Wolters Kluwer Health controlled trial of slowing of kidney disease progression from the inhibition of xanthine oxidase (ckd-fix)
Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
Controlled Trial Of Slowing Of Kidney Disease Progression From The Inhibition Of Xanthine Oxidase (Ckd Fix), supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckd+progression/controlled+trial+of+slowing+of+kidney+disease+progression+from+the+inhibition+of+xanthine+oxidase++ckd+fix+/10__1097_slash_fjc__0000000000001482-148-12-21
Average 90 stars, based on 1 article reviews
controlled trial of slowing of kidney disease progression from the inhibition of xanthine oxidase (ckd-fix) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Credence Genomics composite ckd progression score index
Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
Composite Ckd Progression Score Index, supplied by Credence Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckd+progression/composite+ckd+progression+score+index/pm36881606-71-8-7
Average 90 stars, based on 1 article reviews
composite ckd progression score index - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
STATA Corporation ckd progression stata
Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
Ckd Progression Stata, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckd+progression/STATA+14%2E0/pm32034854-58-4-6
Average 99 stars, based on 1 article reviews
ckd progression stata - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
STATA Corporation ckd progression
Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
Ckd Progression, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckd+progression/STATA+14%2E0/pmc06050937-252-3-8
Average 99 stars, based on 1 article reviews
ckd progression - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

Image Search Results


Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review

Journal: Journal of Feline Medicine and Surgery

Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

doi: 10.1177/1098612X241234984

Figure Lengend Snippet: Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review

Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

Techniques: Clinical Proteomics, Biomarker Discovery, Concentration Assay

Study type, country and time frame for sample collection, definition of  CKD  and inclusion/exclusion criteria for the studies of fibroblast growth factor 23 in cats

Journal: Journal of Feline Medicine and Surgery

Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

doi: 10.1177/1098612X241234984

Figure Lengend Snippet: Study type, country and time frame for sample collection, definition of CKD and inclusion/exclusion criteria for the studies of fibroblast growth factor 23 in cats

Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

Techniques: Clinical Proteomics, Medications, Concentration Assay, Biomarker Discovery, Imaging

Article characteristics and population information for studies evaluating serum or plasma concentrations of fibroblast growth factor-23 (pg/mL) in healthy cats and in cats with  CKD  stages 1–4

Journal: Journal of Feline Medicine and Surgery

Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

doi: 10.1177/1098612X241234984

Figure Lengend Snippet: Article characteristics and population information for studies evaluating serum or plasma concentrations of fibroblast growth factor-23 (pg/mL) in healthy cats and in cats with CKD stages 1–4

Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

Techniques: Clinical Proteomics

Article characteristics and population information for studies evaluating serum or plasma concentrations of FGF-23 (pg/ml) in cats with progressive or non-progressive  CKD

Journal: Journal of Feline Medicine and Surgery

Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review

doi: 10.1177/1098612X241234984

Figure Lengend Snippet: Article characteristics and population information for studies evaluating serum or plasma concentrations of FGF-23 (pg/ml) in cats with progressive or non-progressive CKD

Article Snippet: Liao et al, 2019 , MyBioSource , CKD – progression , 33 , 11 (8–15) , 245.0 , 201.5 , 491.5.

Techniques: Clinical Proteomics